Tacrolimus is a medicine used to help prevent organ rejection after an organ transplant. It works by stopping the body's immune system from attacking the new organ. It's often taken as a pill or a cream.
Every report comes from a Lived member, sent anonymously.
Have you tried Prograf (Tacrolimus) for Lupus Nephritis?
Tacrolimus is a prescription medicine that lowers the activity of the immune system so it does not attack a transplanted organ. It is one of the main long-term medicines taken after a transplant, and it is always used together with other anti-rejection medicines, such as mycophenolate or a steroid. Prograf, the original brand, is approved to prevent rejection in adults and children who have received a kidney, liver, heart or lung transplant. Two once-daily, extended-release versions are approved only for kidney transplants: Envarsus XR tablets and Astagraf XL capsules. All three contain tacrolimus, but they release it into the body differently, so they are separate products rather than different strengths of the same pill. Doctors sometimes prescribe tacrolimus off-label for certain immune conditions, such as Crohn's disease that has formed fistulas (abnormal tunnels from the bowel). Tacrolimus ointment for eczema is a different skin product with its own uses and risks, and it is not covered here.
Rejection happens when T cells, the white blood cells that coordinate immune attacks, recognize the new organ as foreign and multiply to fight it. To switch on, a T cell relies on an enzyme called calcineurin, which passes the alarm signal into the cell's nucleus. Tacrolimus blocks calcineurin, which is why it is called a calcineurin inhibitor. With that step blocked, T cells make far fewer of the chemical signals that call in more immune cells, and the attack on the organ is held back. The same dampening that protects the organ also weakens the body's defenses against infections and some cancers. Treatment is a balance: enough tacrolimus to prevent rejection, but no more than needed. Its benefit lasts only while it is in the bloodstream, which is why doses are taken every day without gaps.
Prograf comes as capsules and as granules mixed with water for children or people who cannot swallow capsules. It is usually taken twice a day, about 12 hours apart, and can be taken with or without food, as long as it is taken the same way each time. Envarsus XR and Astagraf XL are taken once a day, usually in the morning on an empty stomach, and are swallowed whole without crushing, chewing or splitting. An intravenous form is used in the hospital only for people who cannot yet take it by mouth. The dose is set by weight at first, then adjusted using blood tests that measure the tacrolimus level just before a dose is due (the trough level). Each transplant program sets a target range, typically higher in the first months after surgery and lower later on. Too low a level raises the risk of rejection; too high a level raises the risk of side effects such as kidney damage and tremor. Taking doses at the same times every day keeps these results meaningful. The different tacrolimus products are not interchangeable. Switching between Prograf, a generic immediate-release version and an extended-release product happens only under the transplant team's direction, with follow-up blood levels. If a refill looks different from usual, check with the pharmacist or transplant team before taking it. For a missed dose, follow the instructions for the specific product, and never take a double dose to catch up.
Tremor, often a shaky hand, is one of the most common effects, along with headache, trouble sleeping, tingling in the hands or feet, nausea, diarrhea and constipation. Many of these are more noticeable when blood levels are high and may ease when the dose is adjusted. Several common effects are found mainly through monitoring rather than symptoms. Tacrolimus often raises blood pressure, can reduce kidney function over time, and can raise potassium and lower magnesium in the blood. It can also cause diabetes after transplant, a risk that is higher in African American and Hispanic kidney recipients. Many people need a blood pressure medicine or other treatment for these effects while staying on tacrolimus. Tacrolimus carries the strongest (boxed) warning used by the US Food and Drug Administration (FDA): by lowering immune defenses, it raises the risk of serious infections and of cancers, including lymphoma and skin cancer. Fever, chills, cough, flu-like symptoms, or warm, red, painful skin should be reported to the transplant team right away, since infections can progress faster on immunosuppression. Sun protection and regular skin checks help reduce the skin cancer risk. Contact the team promptly for vision changes, confusion, a worsening tremor, much less urine than usual, or unusual thirst and frequent urination. A seizure or loss of consciousness needs emergency care.
Tacrolimus is broken down in the liver by an enzyme system that many other substances speed up or slow down, so interactions are a central part of using it safely. Grapefruit and grapefruit juice raise tacrolimus levels and should be avoided. Some antifungal medicines (such as voriconazole and fluconazole), certain antibiotics (such as clarithromycin and erythromycin), some heart and blood pressure medicines (such as diltiazem and verapamil) and cannabidiol (CBD) can push levels up toward toxicity. Others, including the tuberculosis antibiotic rifampin, some seizure medicines and the herbal supplement St. John's wort, can lower levels enough to risk rejection. Tell every prescriber, dentist and pharmacist about tacrolimus, and check with the transplant team before starting or stopping any medicine or supplement, as an extra blood test may be needed. Because tacrolimus can raise potassium, combining it with other medicines that do the same, such as some blood pressure pills and potassium-sparing water pills, needs care. It can also affect heart rhythm (QT prolongation), which matters more for people with an inherited long QT condition or low potassium or magnesium. Live vaccines, such as the nasal flu vaccine and the measles, mumps and rubella (MMR) vaccine, should be avoided during treatment. Ideally, needed vaccines are given before the transplant. Tacrolimus can harm a developing baby, so anyone who could become pregnant should plan contraception and talk with the transplant team before trying to conceive, rather than stopping the medicine on their own.
In the early weeks after a transplant, blood tests are frequent and the dose may change often. Once levels and organ function are stable, testing becomes less frequent, but it never stops entirely. Illness, vomiting or diarrhea, and new medicines can all shift levels and may call for an extra test. For most transplant recipients, tacrolimus or a similar anti-rejection medicine is lifelong. It protects the organ only while it is being taken, so it is continued even when a person feels completely well, and it should never be stopped without the transplant team. Over time, the team may lower the target level, change the combination of medicines or switch formulations to manage side effects such as kidney strain, diabetes or tremor. Living with tacrolimus usually means building routines: doses at fixed times, keeping blood test appointments, carrying an up-to-date medicine list, avoiding grapefruit and staying alert to infection.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Prograf (Tacrolimus), what you've noticed, or ask the community a question.